Acorda Therapeutics Q2 EPS $(2.29) Misses $(2.09) Estimate, Sales $31.79M Beat $29.94M Estimate
Acorda Therapeutics (NASDAQ:ACOR) reported quarterly losses of $(2.29) per share which missed the analyst consensus estimate of $(2.09) by 9.57 percent. This is a 554.29 percent decrease over losses of $(0.35) per share